Maria Papathanasopoulos to HIV Antibodies
This is a "connection" page, showing publications Maria Papathanasopoulos has written about HIV Antibodies.
Connection Strength
0,667
-
Env-2dCD4 S60C complexes act as super immunogens and elicit potent, broadly neutralizing antibodies against clinically relevant human immunodeficiency virus type 1 (HIV-1). Vaccine. 2015 Nov 17; 33(46):6298-306.
Score: 0,428
-
Engineering and characterising a novel, highly potent bispecific antibody iMab-CAP256 that targets HIV-1. Retrovirology. 2019 11 08; 16(1):31.
Score: 0,142
-
Purification and partial characterization of R5, R5X4, and X4 HIV-1 subtype C envelope glycoproteins expressed in insect cells. J Med Virol. 2005 Aug; 76(4):459-63.
Score: 0,053
-
HIV-1 bispecific antibody iMab-N6 exhibits enhanced breadth but not potency over its parental antibodies iMab and N6. Virol J. 2022 09 07; 19(1):143.
Score: 0,043